Beskrivelse
Krav
IPC-klasse
Fullmektig i Norge:
Fullmektig i EP:
2012.06.01, EP 12170454
CN-A- 102 204 889 (B1)
RHOADES ET AL: "Interactions of an antimicrobial peptide (Ac-RRWWRF-NH"2) and surfactants: Towards antimicrobial peptide additives for coatings applications", PROCESS IN ORGANIC COATINGS, ELSEVIER BV, NL, vol. 58, no. 2-3, 20 February 2007 (2007-02-20), pages 209 - 216, XP005895568, ISSN: 0300-9440, DOI: 10.1016/J.PORGCOAT.2006.09.034 (B1)
SANNES-LOWERY K A ET AL: "HIV-1 TAT PEPTIDE BINDING TO TAR RNA BY ELECTROSPRAY IONIZATION MASS SPECTROMETRY", ANALYTICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 69, no. 24, 15 December 1997 (1997-12-15), pages 5130 - 5135, XP002922152, ISSN: 0003-2700, DOI: 10.1021/AC970745W (B1)
SCHWACH G ET AL: "Biodegradable PLGA microparticles for sustained release of a new GnRH antagonist: part II. In vivo performance", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, vol. 57, no. 3, 1 May 2004 (2004-05-01), pages 441 - 446, XP027111808, ISSN: 0939-6411, [retrieved on 20040413] (B1)
SCHWACH G ET AL: "Biodegradable microparticles for sustained release of a new GnRH antagonist - part I: screening commercial PLGA and formulation technologies", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, vol. 56, no. 3, 1 November 2003 (2003-11-01), pages 327 - 336, XP004470468, ISSN: 0939-6411, DOI: 10.1016/S0939-6411(03)00096-1 (B1)
YI XU ET AL: "A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo", MOLECULAR VISION, 1 January 2010 (2010-01-01), United States, pages 1982, XP055316061, Retrieved from the Internet <URL:http://www.molvis.org/molvis/v16/a214/mv-v16-a214-xu.pdf> (B1)
WO-A1-2010/125468 (B1)
WO-A1-2011/066386 (B1)
WO-A2-2011/004260 (B1)
WO-A2-2012/013331 (B1)
US-A1- 2005 282 731 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP2854831)
|
Utgående
EP Registreringsbrev (3210) (PTEP2854831)
|
Innkommende, AR637714233
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
32413276 expand_more expand_less | 2024.10.11 | 7254 | RWS | Betalt |
Valideringsgebyr EP-patent
7150 = 1 X 7150
Gebyr ved bruk av MasterCard-kort
104 = 104 X 1
|